speb/financial-data huggingface dataset:
CNNE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -15600000.00
CNNE income_statement (quarterly, 2026-03-31) — Normalized Income: -28620000.00
CNNE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -21200000.00
CNNE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 5800000.00
CNNE income_statement (quarterly, 2026-03-31) — Operating Income: -22100000.00
CNNE income_statement (quarterly, 2026-03-31) — Operating Revenue: 91900000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 45611416.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 24900000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5800000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 6000000.00
CNNE income_statement (quarterly, 2026-03-31) — Other Income Expense: -7200000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 12700000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 26700000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 12300000.00
CNNE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -1400000.00
CNNE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 20600000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Other Properties: 153200000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Payables: 86500000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 86500000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CNNE income_statement (quarterly, 2026-03-31) — Pretax Income: -29500000.00
CNNE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -400000.00
CNNE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -2100000.00
CNNE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1800000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Receivables: 48100000.00
CNNE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 91900000.00
CNNE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5800000.00
CNNE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -14700000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -27500000.00
CNNE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 0.00
CNNE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 0.00
CNNE cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CNNE balance_sheet (quarterly, 2026-03-31) — Share Issued: 95320747.00
CNNE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2200000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 958900000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 892800000.00
CNNE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2320000.00
CNNE income_statement (quarterly, 2026-03-31) — Tax Provision: 500000.00
CNNE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CNNE balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 48100000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Assets: 1239600000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1023400000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Debt: 203900000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 922400000.00
CNNE income_statement (quarterly, 2026-03-31) — Total Expenses: 118300000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 317200000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1030900000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 194800000.00
CNNE income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -22100000.00
CNNE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -5800000.00
CNNE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -5800000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 49709331.00
CNNE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 1063100000.00
CNNE balance_sheet (quarterly, 2026-03-31) — Working Capital: 86300000.00
CNO income_statement (annual, 2021-12-31) — Amortization: 281100000.00
CNO balance_sheet (annual, 2021-12-31) — Current Debt: 0.00
CNO balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 0.00
CNO income_statement (annual, 2021-12-31) — Depreciation And Amortization In Income Statement: 281100000.00
CNO balance_sheet (annual, 2021-12-31) — Line Of Credit: 0.00
CNO income_statement (annual, 2022-12-31) — +Total Revenue: 3576800000.00
CNO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 4223400000.00
CNO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2033800000.00
CNO income_statement (annual, 2022-12-31) — Amortization: 309600000.00
CNO cash_flow (annual, 2022-12-31) — Amortization Of Securities: -336000000.00
CNO income_statement (annual, 2022-12-31) — Basic Average Shares: 115733000.00
CNO income_statement (annual, 2022-12-31) — Basic EPS: 3.43
CNO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 731700000.00
CNO balance_sheet (annual, 2022-12-31) — Capital Stock: 1100000.00
CNO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 69200000.00
CNO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 20422600000.00
CNO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -64800000.00
CNO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1199100000.00
CNO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1781300000.00
CNO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 495400000.00
CNO cash_flow (annual, 2022-12-31) — Change In Working Capital: -374700000.00
CNO cash_flow (annual, 2022-12-31) — Changes In Cash: -86800000.00
CNO balance_sheet (annual, 2022-12-31) — Common Stock: 1100000.00
CNO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -64800000.00
CNO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1768800000.00
CNO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 13500000.00
CNO cash_flow (annual, 2022-12-31) — Common Stock Payments: -190100000.00
CNO balance_sheet (annual, 2022-12-31) — Current Debt: 0.00
CNO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 0.00
CNO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 152000000.00
CNO cash_flow (annual, 2022-12-31) — Deferred Tax: 152000000.00
CNO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 248500000.00
CNO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 309600000.00
CNO income_statement (annual, 2022-12-31) — Diluted Average Shares: 117717000.00
CNO income_statement (annual, 2022-12-31) — Diluted EPS: 3.37
CNO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 630600000.00
CNO income_statement (annual, 2022-12-31) — EBIT: 953500000.00
CNO cash_flow (annual, 2022-12-31) — End Cash Position: 644900000.00
CNO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 1199100000.00
CNO cash_flow (annual, 2022-12-31) — Free Cash Flow: 495400000.00
CNO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 135400000.00
CNO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -1957300000.00
CNO income_statement (annual, 2022-12-31) — General And Administrative Expense: 287900000.00
CNO income_statement (annual, 2022-12-31) — Interest Expense: 137000000.00
CNO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 137000000.00
CNO balance_sheet (annual, 2022-12-31) — Invested Capital: 5651700000.00
CNO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1781300000.00
CNO balance_sheet (annual, 2022-12-31) — Investments And Advances: 21774200000.00
CNO balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 1077600000.00
CNO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 13500000.00
CNO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 285000000.00
CNO balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
CNO balance_sheet (annual, 2022-12-31) — Long Term Debt: 3882900000.00
CNO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3882900000.00
CNO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 285000000.00
CNO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -405700000.00
CNO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1077600000.00
CNO income_statement (annual, 2022-12-31) — Loss Adjustment Expense: 1459600000.00
CNO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -176600000.00
CNO balance_sheet (annual, 2022-12-31) — Net Debt: 3813700000.00
CNO income_statement (annual, 2022-12-31) — Net Income: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 630600000.00
CNO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 630600000.00
CNO income_statement (annual, 2022-12-31) — Net Interest Income: -137000000.00
CNO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1720100000.00
CNO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -120700000.00
CNO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -120700000.00
CNO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -137000000.00
CNO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 1561200000.00
CNO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -61200000.00
CNO income_statement (annual, 2022-12-31) — Net Policyholder Benefits And Claims: 1459600000.00
CNO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1768800000.00
CNO income_statement (annual, 2022-12-31) — Normalized Income: 630600000.00
CNO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 495400000.00
CNO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 135400000.00
CNO income_statement (annual, 2022-12-31) — Operating Revenue: 3576800000.00
CNO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 114343070.00
CNO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -1957300000.00
CNO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 39600000.00
CNO income_statement (annual, 2022-12-31) — Other Operating Expenses: 548800000.00
CNO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 20353400000.00
CNO income_statement (annual, 2022-12-31) — Pretax Income: 816500000.00
CNO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -6524400000.00
CNO balance_sheet (annual, 2022-12-31) — Receivables: 5286800000.00
CNO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 248500000.00
CNO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -405700000.00
CNO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -190100000.00
CNO balance_sheet (annual, 2022-12-31) — Retained Earnings: 1691200000.00
CNO income_statement (annual, 2022-12-31) — Salaries And Wages: 287900000.00
CNO cash_flow (annual, 2022-12-31) — Sale Of Investment: 4804300000.00
CNO income_statement (annual, 2022-12-31) — Selling General And Administration: 287900000.00
CNO balance_sheet (annual, 2022-12-31) — Share Issued: 114343070.00
CNO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CNO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1768800000.00
CNO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1768800000.00
CNO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CNO income_statement (annual, 2022-12-31) — Tax Provision: 185900000.00
CNO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CNO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1063400000.00
CNO balance_sheet (annual, 2022-12-31) — Total Assets: 33133100000.00
CNO balance_sheet (annual, 2022-12-31) — Total Capitalization: 5651700000.00
CNO balance_sheet (annual, 2022-12-31) — Total Debt: 3882900000.00
CNO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1768800000.00
CNO income_statement (annual, 2022-12-31) — Total Expenses: 2760300000.00
CNO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 31364300000.00
CNO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CNO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CNO income_statement (annual, 2023-12-31) — +Total Revenue: 4146800000.00
CNO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 4040700000.00
CNO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1891500000.00
CNO cash_flow (annual, 2023-12-31) — Amortization Of Securities: -377900000.00
CNO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
CNO income_statement (annual, 2023-12-31) — Basic Average Shares: 113275000.00
CNO income_statement (annual, 2023-12-31) — Basic EPS: 2.44
CNO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 644900000.00
CNO balance_sheet (annual, 2023-12-31) — Capital Stock: 1100000.00
CNO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 774500000.00
CNO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 22280700000.00
CNO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -68100000.00
CNO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 533500000.00
CNO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -872300000.00
CNO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 582900000.00
CNO cash_flow (annual, 2023-12-31) — Change In Working Capital: 449700000.00
CNO cash_flow (annual, 2023-12-31) — Changes In Cash: 244100000.00
CNO balance_sheet (annual, 2023-12-31) — Common Stock: 1100000.00
CNO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -68100000.00
CNO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 2215600000.00
CNO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 13200000.00
CNO cash_flow (annual, 2023-12-31) — Common Stock Payments: -166100000.00
CNO balance_sheet (annual, 2023-12-31) — Current Debt: 0.00
CNO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 0.00
CNO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 21100000.00
CNO cash_flow (annual, 2023-12-31) — Deferred Tax: 21100000.00
CNO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 267400000.00
CNO income_statement (annual, 2023-12-31) — Diluted Average Shares: 115124000.00
CNO income_statement (annual, 2023-12-31) — Diluted EPS: 2.40
CNO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 276500000.00
CNO income_statement (annual, 2023-12-31) — EBIT: 595400000.00
CNO cash_flow (annual, 2023-12-31) — End Cash Position: 889000000.00
CNO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 533500000.00
CNO cash_flow (annual, 2023-12-31) — Free Cash Flow: 582900000.00
CNO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 69000000.00
CNO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -1576800000.00
CNO income_statement (annual, 2023-12-31) — General And Administrative Expense: 290900000.00
CNO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CNO income_statement (annual, 2023-12-31) — Interest Expense: 238600000.00
CNO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 238600000.00
CNO balance_sheet (annual, 2023-12-31) — Invested Capital: 6366200000.00
CNO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -872300000.00
CNO balance_sheet (annual, 2023-12-31) — Investments And Advances: 22594400000.00
CNO balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 768600000.00
CNO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 13200000.00
CNO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 995500000.00
CNO balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
CNO balance_sheet (annual, 2023-12-31) — Long Term Debt: 4150600000.00
CNO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 4150600000.00
CNO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 995500000.00
CNO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -736800000.00
CNO balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 768600000.00
CNO income_statement (annual, 2023-12-31) — Loss Adjustment Expense: 2275700000.00
CNO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -152900000.00
CNO balance_sheet (annual, 2023-12-31) — Net Debt: 3376100000.00
CNO income_statement (annual, 2023-12-31) — Net Income: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 276500000.00
CNO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 276500000.00
CNO income_statement (annual, 2023-12-31) — Net Interest Income: -238600000.00
CNO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -835700000.00
CNO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 258700000.00
CNO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 258700000.00
CNO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -238600000.00
CNO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 495800000.00
CNO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -36600000.00
CNO income_statement (annual, 2023-12-31) — Net Policyholder Benefits And Claims: 2275700000.00
CNO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 2215600000.00
CNO income_statement (annual, 2023-12-31) — Normalized Income: 276500000.00
CNO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 582900000.00
CNO cash_flow (annual, 2023-12-31) — Operating Gains Losses: 69000000.00
CNO income_statement (annual, 2023-12-31) — Operating Revenue: 4146800000.00
CNO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 109357540.00
CNO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -1576800000.00
CNO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -122900000.00
CNO income_statement (annual, 2023-12-31) — Other Operating Expenses: 646300000.00
CNO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 21506200000.00
CNO income_statement (annual, 2023-12-31) — Pretax Income: 356800000.00
CNO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -3621300000.00
CNO balance_sheet (annual, 2023-12-31) — Receivables: 4976900000.00
CNO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 267400000.00
CNO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -736800000.00
CNO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -166100000.00
CNO balance_sheet (annual, 2023-12-31) — Retained Earnings: 1899800000.00
CNO income_statement (annual, 2023-12-31) — Salaries And Wages: 290900000.00
CNO cash_flow (annual, 2023-12-31) — Sale Of Investment: 2785600000.00
CNO income_statement (annual, 2023-12-31) — Selling General And Administration: 290900000.00
CNO balance_sheet (annual, 2023-12-31) — Share Issued: 109357540.00
CNO income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CNO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 2215600000.00
CNO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 2215600000.00
CNO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CNO income_statement (annual, 2023-12-31) — Tax Provision: 80300000.00
CNO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.23
CNO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 936200000.00
CNO balance_sheet (annual, 2023-12-31) — Total Assets: 35027100000.00
CNO balance_sheet (annual, 2023-12-31) — Total Capitalization: 6366200000.00
CNO balance_sheet (annual, 2023-12-31) — Total Debt: 4150600000.00
CNO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 2215600000.00
CNO income_statement (annual, 2023-12-31) — Total Expenses: 3790000000.00
CNO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 32811500000.00
CNO income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
CNO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CNO balance_sheet (quarterly, 2024-09-30) — Current Debt: 0.00
CNO balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 0.00
CNO balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 0.00
CNO income_statement (quarterly, 2024-09-30) — Other Special Charges: -100000.00
CNO cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: -12600000.00
CNO income_statement (annual, 2024-12-31) — +Total Revenue: 4445600000.00
CNO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3854700000.00
CNO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1632500000.00
CNO cash_flow (annual, 2024-12-31) — Amortization Of Securities: -445700000.00
CNO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CNO income_statement (annual, 2024-12-31) — Basic Average Shares: 106144000.00
CNO income_statement (annual, 2024-12-31) — Basic EPS: 3.81
CNO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 889000000.00
CNO balance_sheet (annual, 2024-12-31) — Capital Stock: 1000000.00
CNO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1656700000.00
CNO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 24386800000.00
CNO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -67700000.00
CNO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 1969600000.00
CNO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1488600000.00
CNO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 627700000.00
CNO cash_flow (annual, 2024-12-31) — Change In Working Capital: 534700000.00
CNO cash_flow (annual, 2024-12-31) — Changes In Cash: 1108700000.00
CNO balance_sheet (annual, 2024-12-31) — Common Stock: 1000000.00
CNO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -67700000.00
CNO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2515200000.00
CNO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 11200000.00
CNO cash_flow (annual, 2024-12-31) — Common Stock Payments: -300200000.00
CNO cash_flow (annual, 2024-12-31) — Deferred Income Tax: 63900000.00
CNO cash_flow (annual, 2024-12-31) — Deferred Tax: 63900000.00
CNO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 292400000.00
CNO income_statement (annual, 2024-12-31) — Diluted Average Shares: 108116000.00
CNO income_statement (annual, 2024-12-31) — Diluted EPS: 3.74
CNO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 420800000.00
CNO income_statement (annual, 2024-12-31) — EBIT: 794300000.00
CNO cash_flow (annual, 2024-12-31) — End Cash Position: 1997700000.00
CNO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 1969600000.00
CNO cash_flow (annual, 2024-12-31) — Free Cash Flow: 627700000.00
CNO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 49900000.00
CNO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1371400000.00
CNO income_statement (annual, 2024-12-31) — General And Administrative Expense: 304500000.00
CNO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CNO income_statement (annual, 2024-12-31) — Interest Expense: 254400000.00
CNO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 254400000.00
CNO balance_sheet (annual, 2024-12-31) — Invested Capital: 7035100000.00
CNO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1488600000.00
CNO balance_sheet (annual, 2024-12-31) — Investments And Advances: 23740500000.00
CNO balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 433800000.00
CNO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 11200000.00
CNO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 1579200000.00
CNO balance_sheet (annual, 2024-12-31) — Long Term Debt: 4519900000.00
CNO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 4519900000.00
CNO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 1579200000.00
CNO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1223600000.00
CNO balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 433800000.00
CNO income_statement (annual, 2024-12-31) — Loss Adjustment Expense: 2348700000.00
CNO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -289000000.00
CNO balance_sheet (annual, 2024-12-31) — Net Debt: 2863200000.00
CNO income_statement (annual, 2024-12-31) — Net Income: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 420800000.00
CNO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 420800000.00
CNO income_statement (annual, 2024-12-31) — Net Interest Income: -254400000.00
CNO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -1475100000.00
CNO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 355600000.00
CNO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 355600000.00
CNO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -254400000.00
CNO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1970700000.00
CNO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -13500000.00
CNO income_statement (annual, 2024-12-31) — Net Policyholder Benefits And Claims: 2348700000.00
CNO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2515200000.00
CNO income_statement (annual, 2024-12-31) — Normalized Income: 417758000.00
CNO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 627700000.00
CNO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 49900000.00
CNO income_statement (annual, 2024-12-31) — Operating Revenue: 4445600000.00
CNO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 101618957.00
CNO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1371400000.00
CNO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -288300000.00
CNO income_statement (annual, 2024-12-31) — Other Operating Expenses: 629000000.00
CNO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 22730100000.00
CNO income_statement (annual, 2024-12-31) — Other Special Charges: -3900000.00
CNO income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CNO income_statement (annual, 2024-12-31) — Pretax Income: 539900000.00
CNO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -6890500000.00
CNO balance_sheet (annual, 2024-12-31) — Receivables: 4668800000.00
CNO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 292400000.00
CNO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1223600000.00
CNO cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -300200000.00
CNO balance_sheet (annual, 2024-12-31) — Retained Earnings: 2253100000.00
CNO income_statement (annual, 2024-12-31) — Salaries And Wages: 304500000.00
CNO cash_flow (annual, 2024-12-31) — Sale Of Investment: 5415400000.00
CNO income_statement (annual, 2024-12-31) — Selling General And Administration: 304500000.00
CNO balance_sheet (annual, 2024-12-31) — Share Issued: 101618957.00
CNO income_statement (annual, 2024-12-31) — Special Income Charges: 3900000.00
CNO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2515200000.00
CNO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2515200000.00
CNO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 858000.00
CNO income_statement (annual, 2024-12-31) — Tax Provision: 119100000.00
CNO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.22
CNO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 814100000.00
CNO balance_sheet (annual, 2024-12-31) — Total Assets: 37849300000.00
CNO balance_sheet (annual, 2024-12-31) — Total Capitalization: 7035100000.00
CNO balance_sheet (annual, 2024-12-31) — Total Debt: 4519900000.00
CNO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2515200000.00
CNO income_statement (annual, 2024-12-31) — Total Expenses: 3905700000.00
CNO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 35334100000.00
CNO income_statement (annual, 2024-12-31) — Total Unusual Items: 3900000.00
CNO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 3900000.00
CNO income_statement (quarterly, 2025-03-31) — +Total Revenue: 1004100000.00
CNO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3804300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1535000000.00
CNO cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -114100000.00
CNO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 100743000.00
CNO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.14
CNO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1997700000.00
CNO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000000.00
CNO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 928200000.00
CNO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 8839700000.00
CNO cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -16900000.00
CNO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -571400000.00
CNO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -538200000.00
CNO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 136700000.00
CNO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 105300000.00
CNO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -972900000.00
CNO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000000.00
CNO cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -16900000.00
CNO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2530500000.00
CNO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 6500000.00
CNO cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -110300000.00
CNO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 8900000.00
CNO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 8900000.00
CNO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 77800000.00
CNO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 103070000.00
CNO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.13
CNO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — EBIT: 89800000.00
CNO cash_flow (quarterly, 2025-03-31) — End Cash Position: 1024800000.00
CNO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -571400000.00
CNO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 136700000.00
CNO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 13400000.00
CNO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1239100000.00
CNO income_statement (quarterly, 2025-03-31) — Interest Expense: 62000000.00
CNO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 62000000.00
CNO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6928400000.00
CNO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -538200000.00
CNO balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 24320300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 380200000.00
CNO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 6500000.00
CNO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 234500000.00
CNO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4397900000.00
CNO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4397900000.00
CNO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 234500000.00
CNO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -356100000.00
CNO balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 380200000.00
CNO income_statement (quarterly, 2025-03-31) — Loss Adjustment Expense: 573100000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -103800000.00
CNO balance_sheet (quarterly, 2025-03-31) — Net Debt: 3469700000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 21500000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 21500000.00
CNO income_statement (quarterly, 2025-03-31) — Net Interest Income: -62000000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -534800000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -121600000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -121600000.00
CNO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -62000000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -329100000.00
CNO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -3400000.00
CNO income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 573100000.00
CNO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2530500000.00
CNO income_statement (quarterly, 2025-03-31) — Normalized Income: 20337500.00
CNO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 136700000.00
CNO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 13400000.00
CNO income_statement (quarterly, 2025-03-31) — Operating Revenue: 1004100000.00
CNO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 99893923.00
CNO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1239100000.00
CNO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 30500000.00
CNO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 275300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 7911500000.00
CNO income_statement (quarterly, 2025-03-31) — Other Special Charges: -1500000.00
CNO income_statement (quarterly, 2025-03-31) — Pretax Income: 27800000.00
CNO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -1639700000.00
CNO balance_sheet (quarterly, 2025-03-31) — Receivables: 4579400000.00
CNO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 77800000.00
CNO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -356100000.00
CNO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -110300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2233600000.00
CNO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 1104900000.00
CNO balance_sheet (quarterly, 2025-03-31) — Share Issued: 99893923.00
CNO income_statement (quarterly, 2025-03-31) — Special Income Charges: 1500000.00
CNO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2530500000.00
CNO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2530500000.00
CNO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 337500.00
CNO income_statement (quarterly, 2025-03-31) — Tax Provision: 6300000.00
CNO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.23
CNO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 775100000.00
CNO balance_sheet (quarterly, 2025-03-31) — Total Assets: 37436300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6928400000.00
CNO balance_sheet (quarterly, 2025-03-31) — Total Debt: 4397900000.00
CNO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2530500000.00
CNO income_statement (quarterly, 2025-03-31) — Total Expenses: 976300000.00
CNO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 34905800000.00
CNO income_statement (quarterly, 2025-03-31) — Total Unusual Items: 1500000.00
CNO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 1500000.00
CNO cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -6600000.00
CNO income_statement (quarterly, 2025-06-30) — +Total Revenue: 1151500000.00
CNO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 3753900000.00
CNO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1441400000.00
CNO cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -130700000.00
CNO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 98572000.00
CNO income_statement (quarterly, 2025-06-30) — Basic EPS: 0.93
CNO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1024800000.00
CNO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000000.00
CNO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 766000000.00
CNO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8253400000.00
CNO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -16700000.00
CNO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -232100000.00
CNO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -122200000.00
CNO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 145500000.00
CNO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 160400000.00
CNO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -208800000.00
CNO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000000.00
CNO cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -16700000.00
CNO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2522700000.00
CNO cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 600000.00
CNO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -100300000.00
CNO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 23400000.00
CNO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 23400000.00
CNO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 78800000.00
CNO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 100386000.00
CNO income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.91
CNO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — EBIT: 177100000.00
CNO cash_flow (quarterly, 2025-06-30) — End Cash Position: 816000000.00
CNO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -232100000.00
CNO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 145500000.00
CNO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 11800000.00
CNO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1252700000.00
CNO income_statement (quarterly, 2025-06-30) — Interest Expense: 59100000.00
CNO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 59100000.00
CNO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 6651900000.00
CNO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -122200000.00
CNO balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 24119600000.00
CNO balance_sheet (quarterly, 2025-06-30) — Investments In Other Ventures Under Equity Method: 376900000.00
CNO cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 600000.00
CNO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 292300000.00
CNO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 4129200000.00
CNO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 4129200000.00
CNO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 292300000.00
CNO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -561500000.00
CNO balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 376900000.00
CNO income_statement (quarterly, 2025-06-30) — Loss Adjustment Expense: 634700000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -99700000.00
CNO balance_sheet (quarterly, 2025-06-30) — Net Debt: 3363200000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 91800000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 91800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Interest Income: -59100000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -116400000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -269200000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -269200000.00
CNO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -59100000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 153500000.00
CNO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -5800000.00
CNO income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 634700000.00
CNO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2522700000.00
CNO income_statement (quarterly, 2025-06-30) — Normalized Income: 91800000.00
CNO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 145500000.00
CNO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 11800000.00
CNO income_statement (quarterly, 2025-06-30) — Operating Revenue: 1151500000.00
CNO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 97319000.00
CNO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1252700000.00
CNO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -96600000.00
CNO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 271100000.00
CNO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 7487400000.00
CNO income_statement (quarterly, 2025-06-30) — Pretax Income: 118000000.00
CNO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1991500000.00
CNO balance_sheet (quarterly, 2025-06-30) — Receivables: 4503200000.00
CNO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 78800000.00
CNO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -561500000.00
CNO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -100300000.00
CNO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 2333000000.00
CNO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 1875100000.00
CNO balance_sheet (quarterly, 2025-06-30) — Share Issued: 97319000.00
CNO income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CNO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2522700000.00
CNO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2522700000.00
CNO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CNO income_statement (quarterly, 2025-06-30) — Tax Provision: 26200000.00
CNO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
CNO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 749300000.00
CNO balance_sheet (quarterly, 2025-06-30) — Total Assets: 37329100000.00
CNO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 6651900000.00
CNO balance_sheet (quarterly, 2025-06-30) — Total Debt: 4129200000.00
CNO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2522700000.00
CNO income_statement (quarterly, 2025-06-30) — Total Expenses: 1033500000.00
CNO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 34806400000.00
CNO income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CNO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CNO income_statement (quarterly, 2025-09-30) — +Total Revenue: 1188700000.00
CNO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3731700000.00
CNO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1389400000.00
CNO cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -133000000.00
CNO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 96603000.00
CNO income_statement (quarterly, 2025-09-30) — Basic EPS: 0.24
CNO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 816000000.00
CNO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000000.00
CNO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1218300000.00
CNO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8598900000.00
CNO cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -16400000.00
CNO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 333900000.00
CNO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -106100000.00
CNO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 197800000.00
CNO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 195700000.00
CNO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 425600000.00
CNO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000000.00
CNO cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -16400000.00
CNO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2611000000.00
CNO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 2500000.00
CNO cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -60600000.00
CNO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 3800000.00
CNO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 3800000.00
CNO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 80100000.00
CNO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 98553000.00
CNO income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.24
CNO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 23100000.00
CNO income_statement (quarterly, 2025-09-30) — EBIT: 92800000.00
CNO cash_flow (quarterly, 2025-09-30) — End Cash Position: 1241600000.00
CNO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 333900000.00
CNO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 197800000.00